Biotech Experimental Drug Development Centre Announces the Presentation of Updated Data from the Phase 1 Study of Antibody-Drug Conjugate EBC-129 at the 2025 Annual Meeting of the American Society of Clinical Oncology (ASCO) June 4, 2025
Biotech Breakthrough Clinical Data for LBL-024 in First-Line Treatment of Advanced EP-NEC Unveiled at 2025 ASCO Oral Session June 2, 2025
Biotech Biomarkers Market worth US$104.15 billion in 2030 with 10.8% CAGR | MarketsandMarkets™ June 1, 2025
Biotech BioVaxys and Horizon Technology Finance Corp Execute Amendment to Asset Purchase Agreement (“APA”) May 31, 2025
Biotech Innocan Pharma Announces First Quarter 2025 Financial Results with Continued Strong Revenue Growth and Provides Corporate Update May 30, 2025
Biotech Alamar Biosciences joins forces with SciLifeLab to advance understanding of human disease May 28, 2025
Biotech Abbisko Therapeutics Receives CDE Approval of Breakthrough Therapy Designation for Irpagratinib (ABSK011) in the Treatment of HCC May 27, 2025
Biotech Mabwell Announces Clinical Data of Multiple ADCs to be presented at 2025 ASCO Annual Meeting May 26, 2025